CXC chemokines as Molecular Targets for Future Diagnosis and (Renal) Fibrosis Treatment KU Leuven
Renal fibrosis is the final common pathway of chronic kidney disease (CKD), which ultimately leads to end-stage renal disease (ESRD) demanding renal replacement therapy. As such, renal fibrosis is an increasing global health problem. As yet, no adequate preventive or curative therapy is available that can be clinically used to target the development of fibrosis. Chemokines are chemotactic cytokines that are well-known for their ability to ...